Literature DB >> 12397185

Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.

Chunyan Liu1, Jeffrey J Pouliot, Howard A Nash.   

Abstract

Accidental or drug-induced interruption of the breakage and reunion cycle of eukaryotic topoisomerase I (Top1) yields complexes in which the active site tyrosine of the enzyme is covalently linked to the 3' end of broken DNA. The enzyme tyrosyl-DNA phosphodiesterase (Tdp1) hydrolyzes this protein-DNA link and thus functions in the repair of covalent complexes, but genetic studies in yeast show that alternative pathways of repair exist. Here, we have evaluated candidate genes for enzymes that might act in parallel to Tdp1 so as to generate free ends of DNA. Despite finding that the yeast Apn1 protein has a Tdp1-like biochemical activity, genetic inactivation of all known yeast apurinic endonucleases does not increase the sensitivity of a tdp1 mutant to direct induction of Top1 damage. In contrast, assays of growth in the presence of the Top1 poison camptothecin (CPT) indicate that the structure-specific nucleases dependent on RAD1 and MUS81 can contribute independently of TDP1 to repair, presumably by cutting off a segment of DNA along with the topoisomerase. However, cells in which all three enzymes are genetically inactivated are not as sensitive to the lethal effects of CPT as are cells defective in double-strand break repair. We show that the MRE11 gene is even more critical than the RAD52 gene for double-strand break repair of CPT lesions, and comparison of an mre11 mutant with a tdp1 rad1 mus81 triple mutant demonstrates that other enzymes complementary to Tdp1 remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397185      PMCID: PMC137529          DOI: 10.1073/pnas.182557199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Tumor cell death induced by topoisomerase-targeting drugs.

Authors:  T K Li; L F Liu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  3'-phosphodiesterase and 3'-->5' exonuclease activities of yeast Apn2 protein and requirement of these activities for repair of oxidative DNA damage.

Authors:  I Unk; L Haracska; S Prakash; L Prakash
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.

Authors:  J A Simon; P Szankasi; D K Nguyen; C Ludlow; H M Dunstan; C J Roberts; E L Jensen; L H Hartwell; S H Friend
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

4.  Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae.

Authors:  T C Hallstrom; W S Moye-Rowley
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 5.  Base excision repair in yeast and mammals.

Authors:  A Memisoglu; L Samson
Journal:  Mutat Res       Date:  2000-06-30       Impact factor: 2.433

6.  Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group.

Authors:  M A Johnson; P E Bryant; N J Jones
Journal:  Mutagenesis       Date:  2000-07       Impact factor: 3.000

7.  Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.

Authors:  J J Pouliot; K C Yao; C A Robertson; H A Nash
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

8.  Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.

Authors:  J J Pouliot; C A Robertson; H A Nash
Journal:  Genes Cells       Date:  2001-08       Impact factor: 1.891

9.  Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.

Authors:  M H Woo; J R Vance; M A Bjornsti
Journal:  Methods Mol Biol       Date:  2001

10.  Fidelity of mitotic double-strand-break repair in Saccharomyces cerevisiae: a role for SAE2/COM1.

Authors:  A J Rattray; C B McGill; B K Shafer; J N Strathern
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

View more
  76 in total

1.  p53 stimulates human topoisomerase I activity by modulating its DNA binding.

Authors:  Kent Søe; Frank Grosse
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

Review 2.  Mechanisms and regulation of DNA end resection.

Authors:  Maria Pia Longhese; Diego Bonetti; Nicola Manfrini; Michela Clerici
Journal:  EMBO J       Date:  2010-07-20       Impact factor: 11.598

3.  ATP-dependent DNA binding, unwinding, and resection by the Mre11/Rad50 complex.

Authors:  Yaqi Liu; Sihyun Sung; Youngran Kim; Fuyang Li; Gwanghyun Gwon; Aera Jo; Ae-Kyoung Kim; Taeyoon Kim; Ok-Kyu Song; Sang Eun Lee; Yunje Cho
Journal:  EMBO J       Date:  2015-12-30       Impact factor: 11.598

4.  Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer.

Authors:  Chunyan Liu; Shaoyu Zhou; Shahnaz Begum; David Sidransky; William H Westra; Malcolm Brock; Joseph A Califano
Journal:  Lung Cancer       Date:  2006-11-21       Impact factor: 5.705

5.  Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.

Authors:  Karin C Nitiss; Mobeen Malik; Xiaoping He; Stephen W White; John L Nitiss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

6.  Tel1/ATM prevents degradation of replication forks that reverse after topoisomerase poisoning.

Authors:  Luca Menin; Sebastian Ursich; Camilla Trovesi; Ralph Zellweger; Massimo Lopes; Maria Pia Longhese; Michela Clerici
Journal:  EMBO Rep       Date:  2018-05-08       Impact factor: 8.807

Review 7.  Human DNA topoisomerase I: relaxation, roles, and damage control.

Authors:  John B Leppard; James J Champoux
Journal:  Chromosoma       Date:  2005-04-14       Impact factor: 4.316

Review 8.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

9.  Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis.

Authors:  Najoua Dendouga; Hui Gao; Dieder Moechars; Michel Janicot; Jorge Vialard; Clare H McGowan
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.

Authors:  Marc C Rideout; Amy C Raymond; Alex B Burgin
Journal:  Nucleic Acids Res       Date:  2004-08-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.